查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433540

生物安全测试产品和服务市场规模，按产品、应用、测试和地区细分：2024-2030 年趋势分析报告

Biological Safety Testing Products And Services Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Services), By Application, By Test, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

生物安全检测产品和服务市场的成长和趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球生物安全检测产品和服务市场将达93亿美元，2024年至2030年复合年增长率为10.7%。

该市场主要是由生技药品产量的增加所推动的，从而推动了对高效生物安全测试工具的需求。疾病负担的增加是生技药品产量增加的一个主要因素，预计这将推动市场成长。

与生活方式相关的慢性疾病（例如糖尿病和癌症）的盛行率不断增加，是促进药物开发和随后商业化增加的主要因素。预计这将增加确保和审查专门标靶治疗的安全性、评估其结果并避免可能的缺点的需要。此外，生物技术和製药公司越来越多地整合生物安全检测产品和服务，以生产清洁、高活性的生技药品，以解决大量患有目标疾病的人。我就是。病毒性疾病安全测试是生技药品製造、化学和控制的关键组成部分，使其成为许多公司的主要关注点之一。这正在推动市场的成长机会。

基于实验室的污染导致了包含生物安全产品和服务的工作站的开发和改进。对组织培养、维持细胞株无菌和尽量减少交叉污染的需求日益增长，这增加了人们对产品完整性的担忧。政府医疗机构更参与良好生产规范 (GMP) 的实施以及每个生产阶段的后续测试和控制，预计将扩大成长范围。

此外，生物安全检测产品和服务市场的主要公司正在不断开发新产品和技术及其产品系列，以满足全球不断增长的生物安全检测需求，我们正致力于进一步扩大我们的业务。例如，2022 年 12 月 - Charles River Laboratories International, Inc. 是一款全机器人设备，能够处理复杂的稀释液或连续稀释的浓缩物，用于水质测试、进程内测试和最终产品测试。我们进一步扩展了我们的内毒素测试产品组合随着 Endosafe Nexus 200 的推出。结合机器人自动化可以简化品管流程，进而提高整体流程效率。

生物安全检测产品和服务市场报告要点

  • 以产品来看，由于试剂和试剂盒在研究和临床实验室的广泛使用，2023 年试剂和套件产业将占主要收益占有率超过 39.9%。
  • 从应用来看，由于多年来疾病发生率不断增加，疫苗和治疗药物预计将在 2023 年占据市场占有率，并以最快的速度成长。
  • 按测试类型划分，由于细菌感染疾病的增加，内毒素检测领域将在 2023 年占据市场占有率主导地位。
  • 由于生物技术研究投资的增加和慢性病负担的增加，北美地区在2023年以35.13%的收益占有率主导整个市场。因此，预计该地区在预测期内对分子细胞遗传学的需求将会增加。
  • 由于印度和中国等开发中国家医疗支出的增加和医疗基础设施的改善，预计亚太地区在预测期内将以最快的速度成长。

目录

第一章调查方法和范围

第二章生物安全检测产品与服务市场：执行摘要

  • 市场概述
  • 产品和服务简介
  • 使用情况和最终用途简介
  • 竞争形势概览

第三章 生物安全检测产品和服务的市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 增加政府措施和建议的数量
    • 由于疾病负担高，新生技药品的产量增加
    • 对临床和生命科学研究的大量研发投资
  • 市场限制因素分析
    • 核准流程耗时
  • 生物安全检测产品与服务市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析

第四章 生物安全检测产品与服务市场：产品预估与趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 全球生物安全检测产品及服务市场分产品展望
  • 2018年至2030年市场规模、预测与趋势分析

第五章生物安全检测产品与服务市场：应用估算与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 按应用分類的全球生物安全检测产品和服务市场前景
  • 2018年至2030年市场规模、预测、趋势分析

第六章生物安全测试产品与服务市场：测试类型估计与趋势分析

  • 2023 年和 2030 年测试类型市场占有率
  • 细分仪表板
  • 按测试类型分類的全球生物安全测试产品和服务市场前景
  • 2018年至2030年市场规模、预测、趋势分析

第七章 区域业务分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • List of Key Distributors And Channel Partners
    • Key Customers
    • Key Company Market Share Analysis, 2023
    • Charles River Laboratories
    • BSL Bioservice
    • Merck KGaA
    • Samsung Biologics
    • Sartorius AG
    • Eurofins Scientific
    • SGS Societe Generale de Surveillance SA
    • Thermo Fisher Scientific Inc.
    • BIOMERIEUX
    • Lonza
Product Code: GVR-1-68038-140-5

Biological Safety Testing Products And Services Market Growth & Trends:

The global biological safety testing products and services market size is expected to reach USD 9.30 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is predominantly driven by the increasing production of biologics, boosting the demand for highly effective biological safety testing tools. The increasing disease burden is expected to be a major factor responsible for the rising production of biologics, thereby propelling the market growth.

The increasing prevalence of chronic diseases associated with lifestyle, including diabetes and cancer, is a key factor contributing to the rise in drug development and subsequent commercialization. This is expected to increase the need for ensuring & scrutinizing the safety of specialized and targeted therapies, evaluating outcomes, and circumventing probable shortcomings. In addition, biotechnology and pharmaceutical companies are increasingly integrating biological safety testing products and services to produce contamination-free and highly potent biologics to cater to the large number of people suffering from target diseases. Safety testing for viral conditions is proving to be one of the primary concerns of most companies as it is a critical component of manufacturing, chemistry, and control of biologics. This is fueling growth opportunities in the market.

Laboratory-based contamination is leading to the development and refinement of workstations by incorporating biological safety products and services. The increasing need to work with tissue cultures, maintain the sterility of cell lines, and minimize cross-contamination has increased concerns regarding product integrity. Rising involvement by government healthcare organizations for implementing good manufacturing practices and subsequent testing & control at every production stage is expected to widen the scope for growth.

Furthermore, key players operating in the biological safety testing product & services market are constantly focusing on developing novel products and technologies, further expanding their product portfolio, and to meet the rising demand for biological safety testing globally. For instance, in December 2022, -Charles River Laboratories International, Inc. announced the launch of Endosafe Nexus 200, a fully robotic instrument capable of processing both complex or undiluted, serial dilutions for water, in-process, and final product testing, further expanding its endotoxin testing portfolio. The incorporation of automation through robotics has enabled streamlining the quality control process and subsequently improving overall process efficiency.

Biological Safety Testing Products And Services Market Report Highlights:

  • Based on product, the reagents and kits segment held a leading revenue share of over 39.9% in 2023due to their extensive use in research and clinical laboratories
  • Based on application, the vaccines & therapeutics segment dominated in terms of market share in 2023 and is anticipated to grow at fastest growth rate owing to the increase in disease outbreaks over the years
  • Based on test type, the endotoxin tests segment dominated in terms of the market share of in 2023 owing to the rising prevalence of bacterial infections
  • North America dominated the overall market with a revenue share of 35.13% in 2023, owing to rising research investments in biotechnology and the growing burden of chronic diseases. This anticipates increasing the demand for molecular cytogenetics in the region over the forecast period
  • Asia Pacific is anticipated to grow at the fastest growth rate over the forecast period due to growing healthcare spending and the development of healthcare infrastructure in developing countries like India and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. Test Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Biological Safety Testing Products & Services Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products and Services Snapshots
  • 2.3. Application And End-use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Biological Safety Testing Products & Services Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increase number of government initiatives and recommendations
    • 3.4.2. Increasing production of new biologics due to high disease burden
    • 3.4.3. High R&D investments in clinical research and life sciences research
  • 3.5. Market Restraint Analysis
    • 3.5.1. Time-consuming approval process
  • 3.6. Biological Safety Testing Products & Services Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's Five Forces
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Economic Landscape
      • 3.6.2.3. Social Landscape
      • 3.6.2.4. Technological Landscape
      • 3.6.2.5. Environmental Landscape
      • 3.6.2.6. Legal Landscape

Chapter 4. Biological Safety Testing Products & Services Market: Products Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Biological Safety Testing Products & Services Market By Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For The Following
    • 4.4.1. Reagents & Kits
      • 4.4.1.1. Market Estimates and Forecasts 2018 To 2030, (USD Million)
    • 4.4.2. Services
      • 4.4.2.1. Market Estimates and Forecasts 2018 To 2030, (USD Million)
    • 4.4.3. Instruments
      • 4.4.3.1. Market Estimates and Forecasts 2018 To 2030, (USD Million)

Chapter 5. Biological Safety Testing Products & Services Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Biological Safety Testing Products & Services Market By Application Outlook
  • 5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.4.1. Vaccine & Therapeutics Market Revenue Estimates and Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1.1. Vaccines Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1.1.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1.2. Monoclonal Antibodies Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1.2.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1.3. Recombinant Protein Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 5.4.1.1.3.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.2. Blood & Blood-based Products Market Revenue Estimates and Forecasts (USD Million, 2018 - 2030)
      • 5.4.2.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.3. Gene Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.4.3.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.4. Tissue & Tissue-based Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.4.4.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.5. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.4.5.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)

Chapter 6. Biological Safety Testing Products & Services Market: Test Type Estimates & Trend Analysis

  • 6.1. Test Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Biological Safety Testing Products & Services Market By Test Type Outlook
  • 6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 6.4.1. Endotoxin Tests
      • 6.4.1.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 6.4.2. Sterility Tests
      • 6.4.2.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 6.4.3. Cell Line Authentication & Characterization Tests
      • 6.4.3.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 6.4.4. Bioburden Tests
      • 6.4.4.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 6.4.5. Adventitious Agent Detection Tests
      • 6.4.5.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 6.4.6. Residual Host Contamination Detection Tests
      • 6.4.6.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 6.4.7. Others
      • 6.4.7.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Competitive Scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. U.S. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.5.2. Canada
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Canada Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Competitive Scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. UK Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.2. Germany
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Germany Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.3. Spain
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Spain Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. France Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Italy Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.6. Denmark
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Denmark Market Estimates And Forecasts (USD Million, 2018 - 2030)
      • 7.6.6.5.
    • 7.6.7. Sweden
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Sweden Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.8. Norway
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Norway Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Japan Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. China Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. India Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.7.4. South Korea
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. South Korea Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.7.5. Thailand
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Thailand Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Australia Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. Brazil Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.8.2. Mexico
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Mexico Biological Safety Testing Products & Services Market, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Argentina Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Competitive Scenario
      • 7.9.1.3. Regulatory Framework
      • 7.9.1.4. South Africa Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Saudi Arabia Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. UAE Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Kuwait Market Estimates And Forecasts (USD Million, 2018 - 2030)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company /Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of Key Distributors And Channel Partners
    • 8.3.2. Key Customers
    • 8.3.3. Key Company Market Share Analysis, 2023
    • 8.3.4. Charles River Laboratories
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. BSL Bioservice
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Merck KGaA
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Samsung Biologics
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Sartorius AG
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Eurofins Scientific
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. SGS Societe Generale de Surveillance SA
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Thermo Fisher Scientific Inc.
      • 8.3.11.1. Overview
      • 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. BIOMERIEUX
      • 8.3.12.1. Overview
      • 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Lonza
      • 8.3.13.1. Overview
      • 8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 North America Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 9 Canada Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 Canada Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 Canada Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 12 Europe Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Europe Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 Europe Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 16 UK Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 UK Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 UK Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 19 Germany Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Germany Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 Germany Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 22 France Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 France Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 France Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 25 Italy Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Italy Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Italy Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 28 Spain Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Spain Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Spain Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 31 Sweden Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Sweden Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Sweden Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 34 Norway Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Norway Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Norway Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Denmark Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 44 Japan Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Japan Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Japan Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 47 China Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 China Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 China Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 50 India Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 India Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 India Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 53 Australia Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Australia Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Australia Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 56 South Korea Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 South Korea Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 59 Thailand Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 62 Latin America Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Latin America Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 66 Brazil Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Brazil Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Brazil Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 69 Argentina Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 70 Argentina Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Argentina Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 72 Mexico Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Mexico Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Mexico Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 75 MEA Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 MEA Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 MEA Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 79 South Africa Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 85 UAE Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 UAE Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 UAE Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews In North America
  • Fig. 5 Primary Interviews In Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews In Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling For Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Biological Safety Testing Products & Services Market: Market Outlook
  • Fig. 14 Biological Safety Testing Products & Services Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Biological Safety Testing Products & Services Market Driver Impact
  • Fig. 20 Biological Safety Testing Products & Services Market Restraint Impact
  • Fig. 21 Biological Safety Testing Products & Services Market Strategic Initiatives Analysis
  • Fig. 22 Biological Safety Testing Products & Services Market: Product Movement Analysis
  • Fig. 23 Biological Safety Testing Products & Services Market: Product Outlook And Key Takeaways
  • Fig. 24 Reagents & Kits Market Estimates And Forecast (USD Million, 2018 - 2030)
  • Fig. 25 Services Estimates And Forecast (USD Million, 2018 - 2030)
  • Fig. 26 Instruments Estimates And Forecast (USD Million, 2018 - 2030)
  • Fig. 27 Biological Safety Testing Products & Services Market: Application Movement Analysis
  • Fig. 28 Biological Safety Testing Products & Services Market: Application Outlook And Key Takeaways
  • Fig. 29 Vaccines & therapeutics Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 30 Blood & Blood-based Products Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 31 Gene Therapy Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 32 Tissue & Tissue-based Products Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 33 Stem Cell Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 34 Biological Safety Testing Products & Services Market: Test Type Movement Analysis
  • Fig. 35 Biological Safety Testing Products & Services Market: End-use Outlook And Key Takeaways
  • Fig. 36 Endotoxin Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 37 Sterility Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 38 Cell Line Authentication & Characterization Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 39 Bioburden Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 40 Adventitious Agent Detection Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 41 Residual Host Contamination Detection Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 42 Other Test Types Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • Fig. 43 Global Biological Safety Testing Products & Services Market: Regional Movement Analysis
  • Fig. 44 Global Biological Safety Testing Products & Services Market: Regional Outlook And Key Takeaways
  • Fig. 45 Global Biological Safety Testing Products & Services Market Share And Leading Players
  • Fig. 46 North America Market Share And Leading Players
  • Fig. 47 Europe Market Share And Leading Players
  • Fig. 48 Asia Pacific Market Share And Leading Players
  • Fig. 49 Latin America Market Share And Leading Players
  • Fig. 50 Middle East & Africa Market Share And Leading Players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, By Country
  • Fig. 57 North America
  • Fig. 58 North America Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 59 U.S.
  • Fig. 60 U.S. Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 61 Canada
  • Fig. 62 Canada Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 63 Europe
  • Fig. 64 Europe Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 65 UK
  • Fig. 66 UK Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 67 Germany
  • Fig. 68 Germany Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 69 France
  • Fig. 70 France Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 71 Italy
  • Fig. 72 Italy Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 73 Spain
  • Fig. 74 Spain Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 75 Denmark
  • Fig. 76 Denmark Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 77 Sweden
  • Fig. 78 Sweden Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 79 Norway
  • Fig. 80 Norway Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 83 China
  • Fig. 84 China Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 85 Japan
  • Fig. 86 Japan Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 87 India
  • Fig. 88 India Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 89 Thailand
  • Fig. 90 Thailand Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 91 South Korea
  • Fig. 92 South Korea Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 93 Australia
  • Fig. 94 Australia Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 95 Latin America
  • Fig. 96 Latin America Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 97 Brazil
  • Fig. 98 Brazil Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 99 Mexico
  • Fig. 100 Mexico Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 101 Argentina
  • Fig. 102 Argentina Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 103 Middle East And Africa
  • Fig. 104 Middle East And Africa Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 105 South Africa
  • Fig. 106 South Africa Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 109 UAE
  • Fig. 110 UAE Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait Market Estimates And Forecasts, (USD Million, 2018 - 2030)
  • Fig. 113 Market Share Of Key Market Players - Biological Safety Testing Products & Services Market